Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CMS In Brief

This article was originally published in The Gray Sheet

Executive Summary

CMS expands coverage of PET for solid tumors: Agency finalizes its coverage reconsideration Aug. 4 on positron emission tomography for solid tumors and myeloma, easing its previous strict limit of one FDG PET study per patient during the initial treatment stages. While CMS will continue to nationally cover only one PET scan to determine the location and/or extent of a tumor for therapeutic purposes related to the initial treatment strategy, local Medicare contractors will now have discretion to determine whether to cover additional PET scans as needed during the initial treatment stage. CMS opened the reconsideration late last year at the request of several radiology and nuclear medicine professional societies (1"The Gray Sheet" Nov. 16, 2009)

You may also be interested in...



Preventive Service Regs Could Give Screening Tools A Boost

Preventive services including colonoscopies, mammograms and diabetes screenings may become more accessible under a federal government plan announced July 14

Outpatient Payment Draft Supports Preventive Health Care Screening Tests

Medicare beneficiaries would no longer have to pay coinsurance for certain colorectal cancer screening tests under CMS' 2011 Outpatient Prospective Payment System proposed rule

Hospitals Want To Work With Vendors In Value-Based Purchasing

As hospitals gear up for a value-based purchasing program mandated by the recently enacted health reform law, a new cottage industry is likely to grow among firms pitching products and services that address health care quality measures, according to Richard Bankowitz, chief medical officer for group purchasing organization Premier

Related Content

Topics

UsernamePublicRestriction

Register

MT029219

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel